HSS’ Dr. Christopher Mendias earns $800k grant for stem cell research — 5 notes – Becker’s Orthopedic & Spine
|
HSS’ Dr. Christopher Mendias earns $800k grant for stem cell research — 5 notes
Becker’s Orthopedic & Spine The Orthopaedic Research and Education Foundation and National Stem Cell Foundation gave Christopher L. Mendias, PhD, of New York City-based Hospital for Special Surgery, a research grant. Here are five notes: 1. Dr. Mendias earned the OREF Clinical … |
|
New Gene Therapies Could Change Hemophilia Forever
Motley Fool At last week’s American Society of Hemophilia conference, Spark Therapeutics (NASDAQ:ONCE) and BioMarin (NASDAQ:BMRN) presented promising data for gene therapy drugs that could change the way hemophilia is treated, making patients’ lives significantly … |
|
FDA Approves Gene Therapy for Rare Form of Blindness
U.S. News & World Report TUESDAY, Dec. 19, 2017 (HealthDay News) — A new gene therapy to treat children and adults with a rare type of inherited vision loss has been approved by the U.S. Food and Drug Administration. It’s the first gene therapy approved in the United States … |
|
Spark grabs FDA nod for Luxturna, a breakthrough gene therapy likely bearing a pioneering price
FiercePharma Luxturna is now Spark’s only approved med and works by delivering a gene called RPE65 into a patient’s retinal cells, which then produce a protein to restore vision loss. The one-time treatment uses a naturally occurring adeno-associated virus to … |